Get started
Author

Jason L. Lukas

The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2013 · Imke Listerman, Jie Sun, et al. · Cancer Research · 158
IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu -Transgenic Mice
2006 · Keith L Knutson, Yushe Dang, et al. · The Journal of Immunology · 125
PDF
WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
1997 · J Lukas, S Groshen, et al. · Europe PMC (PubMed Central) · 82
Telomerase activity in normal and neoplastic breast.
1997 · J l Tsao, Y Zhao, et al. · PubMed · 50
PDF
p53 Mutations and Expression in Breast Carcinoma in Situ
2000 · Jason Lukas, Ning Niu, et al. · American Journal Of Pathology · 49
PDF
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer
2021 · R. Connor Chick, G. Travis Clifton, et al. · Clinical Immunology · 39
Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors
2019 · G. Travis Clifton, Kaitlin M. Peace, et al. · Clinical Immunology · 24
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
2021 · Ryan C. Lynch, Chaitra S. Ujjani, et al. · Blood · 14
Nucleic Acid Molecular Biomarkers for Diagnostic Biodosimetry Applications: Use of the Fluorogenic 5′-Nuclease Polymerase Chain Reaction Assay
2002 · William F. Blakely, Alexandra C. Miller, et al. · Military Medicine · 13
In vitro organotypic co-culture model for the study of bronchial epithelial clonal outgrowth during multistep lung tumorigenesis.
2004 · Keith L. Knutson, Jason Lukas, et al. · Cancer Research · 1
Data from The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2023 · Imke Listerman, Jie Sun, et al.
Supplementary Methods from The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2023 · Imke Listerman, Jie Sun, et al.
PDF
Supplementary Figure Legend from The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2023 · Imke Listerman, Jie Sun, et al.
Supplementary Tables 1 - 4 from The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2023 · Imke Listerman, Jie Sun, et al.
Supplementary Figures 1 - 9 from The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2023 · Imke Listerman, Jie Sun, et al.
PDF
Abstract P2-14-02: Overall survival following treatment with a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer
2022 · William Williams, Shaker R Dakhil, et al. · Cancer Research
Abstract PS17-20: Response to a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer correlates with tumor grade
2021 · William Williams, Shaker R Dakhil, et al. · Cancer Research
Induction of Therapeutic Breast Cancer Immunity With an IL-2 Immunotoxin
2005 · Keith Knutson, Yushe Dang, et al. · Journal of Immunotherapy
Works count: 18
Citation count: 555
H-index: 9
I10-index: 9
Year
Topic
Type